decibel regeneron hearing loss drug research

Decibel Therapeutics Announces Collaboration with Regeneron to Develop New Drugs to Treat Hearing Loss

Boston-based biotech firm, Decibel Therapeutics, announced a collaboration with Regeneron Pharmaceuticals to boost research efforts to “discover and develop new potential therapeutics to protect, repair, and restore hearing”. As part of the effort, Regeneron will get an equity stake in Decibel and receive royalty payments if the company’s treatments get approved.   Decibel Theraputics, which…

Read More
cochlear drug delivery hearing loss

Intracochlear Drug Delivery Device for Treating Hearing Disorders Heads to Preclinical Testing; Industry Consortium Formed

While there continues to be a growing number of companies developing drugs to treat inner ear disorders, the inner ear remains a particularly challenging organ for targeted drug delivery. Now, however, a novel device to deliver drugs to the inner ear will undergo preclinical testing in an industry consortium. With funding from the National Institute…

Read More